Is It Possible to Prevent or Delay Type 1 Diabetes?
A partnership between JDRF and Janssen Pharmaceuticals seeks ways to intercept the disease before it progresses.
Innovation and the Role of Alternative Markers of Efficacy
The Use and Implementation of Standardized Treatment Pathways
Are Low-Cal Sweeteners at the End of Their Game?
Origins and Evidence Behind New ADA Recommendations for Pediatric A1C
Thyroid Cancer: Increased Incidence or Improved Diagnosis?
